Our News

Pharmazac will exhibit at CPHI Milan 2026, held at Fiera Milano from 6 to 8 October. Our stand is 18G25. Three days of conversations await, covering […]

Pharmazac is celebrating 40 years of operation this year. The Health section of the newspaper TO VIMA has published an article featuring Epameinondas Koronis, VP of […]

The Health section of the widespread Greek newspaper TA NEA has published an anniversary feature marking 40 years of Pharmazac, with an opinion piece by Georgios-Damianos […]

Pharmazac SA is heading to euroPLX 90 in Lisbon on 2 and 3 March 2026, a business-only partnering conference for the pharmaceutical and biopharmaceutical industries. Our […]

Unilog has taken over the distribution of Pharmazac products in Greece as of January 2025. The change was made to keep the supply to the market […]

Pharmazac has been named a Diamond Investor at Naftemporiki’s “Diamonds of the Greek Economy 2024 Awards”, a distinction recognising the company’s investment programme. The awards were […]

Pharmazac has a new head office. We are now based at 1, Anastasiou Zaroliagki & 6, Dimitriou Lamprou, Industrial Area GR-19001 Keratea, Greece, placing our head […]

Pharmazac launches the new product Cinacalcet/Pharmazac in 30mg, 60mg and 90mg F.C. Tablets. Cinacalcet indicated for the treatment of secondary Hyperparathyroidism (HPT) in adult patients with […]

We are welcoming KRKA in Greece and we are supporting them as their distributor! Pharmazac is happy to announce that this collaboration will start in December […]

We are becoming a manufacturer and key player in radiopharmaceuticals ! Pharmazac is happy to announce that its radiopharmaceuticals manufacturing unit in the industrial zone of […]

Pharmazac launches Zaolin, the first generic vinorelbin for oral use (soft caps) in Greece. Zaolin is a chemotherapy drug used to treat non-small cell lung cancer […]

Sugammadex is an intravenous medication given by doctors to rapidly reverse muscle relaxation caused by drugs like rocuronium and vecuronium after surgery. Pharmazac launches the 1st […]